Genome-wide DNA methylation profiling using Infinium® assay - PubMed (original) (raw)
Genome-wide DNA methylation profiling using Infinium® assay
Marina Bibikova et al. Epigenomics. 2009 Oct.
Abstract
Aims: Bisulfite sequence analysis of individual CpG sites within genomic DNA is a powerful approach for methylation analysis in the genome. The major limitation of bisulfite-based methods is parallelization. Both array and next-generation sequencing technology are capable of addressing this bottleneck. In this report, we describe the application of Infinium® genotyping technology to analyze bisulfite-converted DNA to simultaneously query the methylation state of over 27,000 CpG sites from promoters of consensus coding sequences (CCDS) genes.
Materials & methods: We adapted the Infinium genotyping assay to readout an array of over 27,000 pairs of CpG methylation-specific query probes complementary to bisulfite-converted DNA. Two probes were designed to each CpG site: a 'methylated' and an 'unmethylated' query probe. The probe design assumed that all underlying CpG sites were 'in phase' with the queried CpG site due to their close proximity. Bisulfite conversion was performed with a modified version of the Zymo EZ DNA Methylation™ kit.
Results: We applied this technology to measuring methylation levels across a panel of 14 different human tissues, four Coriell cell lines and six cancer cell lines. We observed that CpG sites within CpG islands (CGIs) were largely unmethylated across all tissues (~80% sites unmethylated, β < 0.2), whereas CpG sites in non-CGIs were moderately to highly methylated (only ~12% sites unmethylated, β < 0.2). Within CGIs, only approximately 3-6% of the loci were highly methylated; in contrast, outside of CGIs approximately 25-40% of loci were highly methylated. Moreover, tissue-specific methylation (variation in methylation across tissues) was much more prevalent in non-CGIs than within CGIs.
Conclusion: Our results demonstrate a genome-wide scalable array-based methylation readout platform that is both highly reproducible and quantitative. In the near future, this platform should enable the analysis of hundreds of thousands to millions of CpG sites per sample.
Similar articles
- High density DNA methylation array with single CpG site resolution.
Bibikova M, Barnes B, Tsan C, Ho V, Klotzle B, Le JM, Delano D, Zhang L, Schroth GP, Gunderson KL, Fan JB, Shen R. Bibikova M, et al. Genomics. 2011 Oct;98(4):288-95. doi: 10.1016/j.ygeno.2011.07.007. Epub 2011 Aug 2. Genomics. 2011. PMID: 21839163 - Dynamic changes in DNA methylation patterns in canine lymphoma cell lines demonstrated by genome-wide quantitative DNA methylation analysis.
Yamazaki J, Jelinek J, Hisamoto S, Tsukamoto A, Inaba M. Yamazaki J, et al. Vet J. 2018 Jan;231:48-54. doi: 10.1016/j.tvjl.2017.11.007. Epub 2017 Nov 22. Vet J. 2018. PMID: 29429487 Free PMC article. - A comprehensive evaluation of alignment software for reduced representation bisulfite sequencing data.
Sun X, Han Y, Zhou L, Chen E, Lu B, Liu Y, Pan X, Cowley AW Jr, Liang M, Wu Q, Lu Y, Liu P. Sun X, et al. Bioinformatics. 2018 Aug 15;34(16):2715-2723. doi: 10.1093/bioinformatics/bty174. Bioinformatics. 2018. PMID: 29579198 - Monitoring methylation changes in cancer.
Beier V, Mund C, Hoheisel JD. Beier V, et al. Adv Biochem Eng Biotechnol. 2007;104:1-11. doi: 10.1007/10_024. Adv Biochem Eng Biotechnol. 2007. PMID: 17290816 Review. - Base resolution methylome profiling: considerations in platform selection, data preprocessing and analysis.
Sun Z, Cunningham J, Slager S, Kocher JP. Sun Z, et al. Epigenomics. 2015 Aug;7(5):813-28. doi: 10.2217/epi.15.21. Epub 2015 Sep 14. Epigenomics. 2015. PMID: 26366945 Free PMC article. Review.
Cited by
- Advancing epigenetic profiling in cervical cancer: machine learning techniques for classifying DNA methylation patterns.
Apoorva, Handa V, Batra S, Arora V. Apoorva, et al. 3 Biotech. 2024 Nov;14(11):264. doi: 10.1007/s13205-024-04107-2. Epub 2024 Oct 9. 3 Biotech. 2024. PMID: 39391214 - Applicability of epigenetic age models to next-generation methylation arrays.
Garma LD, Quintela-Fandino M. Garma LD, et al. Genome Med. 2024 Oct 7;16(1):116. doi: 10.1186/s13073-024-01387-4. Genome Med. 2024. PMID: 39375688 Free PMC article. - Telomere length as a predictor of therapy response and survival in patients diagnosed with ovarian carcinoma.
Tomasova K, Seborova K, Kroupa M, Horak J, Kavec M, Vodickova L, Rob L, Hruda M, Mrhalova M, Bartakova A, Bouda J, Fleischer T, Kristensen VN, Vodicka P, Vaclavikova R. Tomasova K, et al. Heliyon. 2024 Jun 29;10(13):e33525. doi: 10.1016/j.heliyon.2024.e33525. eCollection 2024 Jul 15. Heliyon. 2024. PMID: 39050459 Free PMC article. - Advances in Molecular Pathology, Diagnosis and Treatment of Spinal Cord Astrocytomas.
Zhao Z, Song Z, Wang Z, Zhang F, Ding Z, Fan T. Zhao Z, et al. Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241262483. doi: 10.1177/15330338241262483. Technol Cancer Res Treat. 2024. PMID: 39043042 Free PMC article. Review. - mLiftOver: harmonizing data across Infinium DNA methylation platforms.
Chen BH, Zhou W. Chen BH, et al. Bioinformatics. 2024 Jul 1;40(7):btae423. doi: 10.1093/bioinformatics/btae423. Bioinformatics. 2024. PMID: 38963309 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources